Frauke Schultze-Lutter

Frauke Schultze-Lutter

Auto-generated profile, based on publicly available information

Frauke Schultze-Lutter

University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2018 in eLife
Verified
Journal Article
Open access
TGTineke Grent-'T-Jong
Tineke Grent-'T-Jong
JGJoachim Gross
Joachim Gross
JGJozien Goense
Jozien Goense
MWMichael Wibral
Michael Wibral
RGRuchika Gajwani
Ruchika Gajwani
PUPeter J Uhlhaas
Peter J Uhlhaas
We examined alterations in E/I-balance in schizophrenia (ScZ) through measurements of resting-state gamma-band activity in participants meeting clinical high-risk (CHR) criteria (n = 88), 21 first episode (FEP) patients and 34 chronic ScZ-patients. Furthermore, MRS-data were obtained in CHR-participants and matched controls. Magnetoencephalographic (MEG) resting-state activity was examined at source level and MEG-data were correlated with neuropsychological scores and clinical symptoms. CHR-participants were characterized by increased 64–90 Hz power. In contrast, FEP- and ScZ-patients showed aberrant spectral power at both low- and high gamma-band frequencies. MRS-data showed a shift in E/I-balance toward increased excitation in CHR-participants, which correlated with increased occipital gamma-band power. Finally, neuropsychological deficits and clinical symptoms in FEP and ScZ-patients were correlated with reduced gamma band-activity, while elevated psychotic symptoms in the CHR group showed the opposite relationship. The current study suggests that resting-state gamma-band power and altered Glx/GABA ratio indicate changes in E/I-balance parameters across illness stages in ScZ.

1 April 2014 in Schizophrenia Research
Verified
Journal Article
Closed access
FSFrauke Schultze-Lutter
Frauke Schultze-Lutter
JKJoachim Klosterkötter
Joachim Klosterkötter
SRStephan Ruhrmann
Stephan Ruhrmann

1 October 2019 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
NGNicola Groth
Nicola Groth
NSNina Schnyder
Nina Schnyder
MKMichael Kaess
Michael Kaess
AMAndjela Markovic
Andjela Markovic
LRLiz Rietschel
Liz Rietschel
SSStefanie J. Schmidt
Stefanie J. Schmidt

22 April 2016 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
FSFrauke Schultze-Lutter
Frauke Schultze-Lutter
BSBenno G. Schimmelmann
Benno G. Schimmelmann
SSStefanie J. Schmidt
Stefanie J. Schmidt

28 January 2016 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
FSFrauke Schultze-Lutter
Frauke Schultze-Lutter
Martin DebbanéMartin Debbané
Martin Debbané
ATAnastasia Theodoridou
Anastasia Theodoridou
SWStephen J. Wood
Stephen J. Wood
ARAndrea Raballo
Andrea Raballo
PUPeter J. Uhlhaas
Peter J. Uhlhaas
In its initial formulation, the concept of basic symptoms (BSs) integrated findings on the early symptomatic course of schizophrenia and first in vivo evidence of accompanying brain aberrations. It argued that the subtle subclinical disturbances in mental processes described as BSs were the most direct self-experienced expression of the underlying neurobiological aberrations of the disease. Other characteristic symptoms of psychosis (e.g., delusions, hallucinations) were conceptualized as secondary phenomena, resulting from dysfunctional beliefs and suboptimal coping styles with emerging BSs and/or concomitant stressors. While BSs can occur in many mental disorders, in particular affective disorders, a subset of perceptive and cognitive BSs appear to be specific to psychosis and are currently employed in two alternative risk criteria. However, despite their clinical recognition in the early detection of psychosis, neurobiological research on the aetiopathology of psychosis with neuroimaging methods has only just begun to consider the neural correlate of BSs. This perspective paper reviews the emerging evidence of an association between BSs and aberrant brain activation, connectivity patterns, and metabolism, and outlines promising routes for the use of BSs in aetiopathological research on psychosis.

1 September 2021 in Biological Psychiatry
Verified
Journal Article
Open access
TGTineke Grent-‘t-Jong
Tineke Grent-‘t-Jong
RGRuchika Gajwani
Ruchika Gajwani
JGJoachim Gross
Joachim Gross
AGAndrew I. Gumley
Andrew I. Gumley
RKRajeev Krishnadas
Rajeev Krishnadas
PUPeter J. Uhlhaas
Peter J. Uhlhaas
This study aimed to examine whether 40-Hz auditory steady-state responses (ASSRs) are impaired in participants at clinical high-risk for psychosis (CHR-P) and predict clinical outcomes. Magnetoencephalography data were collected during a 40-Hz ASSR paradigm for a group of 116 CHR-P participants, 33 patients with first-episode psychosis (15 antipsychotic-naïve), a psychosis risk-negative group (n = 38), and 49 healthy control subjects. Analysis of group differences of 40-Hz intertrial phase coherence and 40-Hz amplitude focused on right Heschl's gyrus, superior temporal gyrus, hippocampus, and thalamus after establishing significant activations during 40-Hz ASSR stimulation. Linear regression and linear discriminant analyses were used to predict clinical outcomes in CHR-P participants, including transition to psychosis and persistence of attenuated psychotic symptoms (APSs). CHR-P participants and patients with first-episode psychosis were impaired in 40-Hz amplitude in the right thalamus and hippocampus. In addition, patients with first-episode psychosis were impaired in 40-Hz amplitude in the right Heschl's gyrus, and CHR-P participants in 40-Hz intertrial phase coherence in the right Heschl's gyrus. The 40-Hz ASSR deficits were pronounced in CHR-P participants who later transitioned to psychosis (n = 13) or showed persistent APSs (n = 34). Importantly, both APS persistence and transition to psychosis were predicted by 40-Hz ASSR impairments, with ASSR activity in the right hippocampus, superior temporal gyrus, and middle temporal gyrus correctly classifying 69.2% individuals with nonpersistent APSs and 73.5% individuals with persistent APSs (area under the curve = 0.842), and right thalamus 40-Hz activity correctly classifying 76.9% transitioned and 53.6% nontransitioned CHR-P participants (area under the curve = 0.695). Our data indicate that deficits in gamma-band entrainment in the primary auditory cortex and subcortical areas constitute a potential biomarker for predicting clinical outcomes in CHR-P participants.